ND007

N/A

Report date: 2026/03/19 17:16:45

Base Information

Drug NameND007

Drug Alias NameND007

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionInterleukin 23 Receptor inhibitorsAnti-CD3

TargetsInterleukin 23 ReceptorT cell surface glycoprotein CD3

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNumab Therapeutics Ag

China Registration ClassN/A

Develop Information

Active CompaniesNumab Therapeutics Ag

Inactive CompaniesN/A

Active IndicationsInflammation

Inactive IndicationsN/A

Other Information

ATC CodeN/A